CEOi Blood-Based Biomarker Symposium at AAGP 2024

NewsWorkgroup Activities
Written By Knapsack

CEOi held a blood-based biomarker symposium at the American Association for Geriatric Psychiatry (AAGP) 2024 Annual Meeting, “Unleashing Diagnostic Innovation: Clinical Implementation of Blood-Based Biomarkers for Alzheimer’s Disease.”

The symposium was moderated by CEOi’s Ben Tiede, and the expert panel included Allan Levey, Emory University; Kostas Lyketsos, Johns Hopkins University; Jacobo Mintzer, Medical University of South Carolina; and Allyson Rosen, Stanford University.

Knapsack http://www.knapsackcreative.com
Previous

The Global CEO Initiative on Alzheimer’s Disease Announces Expansion of its Blood-Based Biomarker Workgroup in 2024
Next

Panel Discussion at AD/PD 2024